HSP90α Mediates Sorafenib Resistance in Human Hepatocellular Carcinoma by Necroptosis Inhibition under Hypoxia

SIMPLE SUMMARY: Hypoxia is one of the characteristics of most solid tumors and induces cell resistant to chemotherapy. In this paper, we established a hypoxia model in both in vitro and in vivo to investigate the mechanisms of Sorafenib resistance in Hepatocellular carcinoma (HCC). Here, we observed...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Yan, Yang, Yue, Pan, Di, Ding, Youxiang, Zhang, Heng, Ye, Yuting, Li, Jia, Zhao, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827218/
https://www.ncbi.nlm.nih.gov/pubmed/33440739
http://dx.doi.org/10.3390/cancers13020243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827218/
https://www.ncbi.nlm.nih.gov/pubmed/33440739
http://dx.doi.org/10.3390/cancers13020243

Ejemplares similares